Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1044-1051

  Xu, Hua Min ^a   Jiang, Hong ^a   Wang, Jun ^a   Luo, Bing ^a   Xie, Jun Xia ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Adenovirus; Apoptosis; DMT1; Ferrous iron; Oxidative stress

Indexed keywords

CASPASE 3; FERROUS ION; HYDROXYL RADICAL; IRON; MALONALDEHYDE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2;

ADENOVIRUS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; DOPAMINERGIC NERVE CELL; DUODENUM; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; IRON RESPONSIVE ELEMENT; NUCLEOSOME; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BRAIN; CATION TRANSPORT PROTEINS; CELL LINE; CELL LINE, TUMOR; GENETIC VECTORS; HUMANS; HYBRIDOMAS; INTRACELLULAR FLUID; IRON; IRON METABOLISM DISORDERS; IRON-REGULATORY PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS; RATS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; UP-REGULATION;

ADENOVIRIDAE;

EID: 40949165342     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.10.019     Document Type: Article

References (51)

1. Andersen J.K. Does neuronal loss in Parkinson's disease involve programmed cell death?. Bioessays 23 (2001) 640-646
2. Andersen J.K. Iron dysregulation and Parkinson's disease. J. Alzheimer Dis. 6 (2004) 47-52
3. Andrews N.C., Fleming M.D., and Gunshin H. Iron transport across biological membranes. Nutr. Rev. 57 (1999) 114-123
4. Aracena P., Aguirre P., Muñoz P., and Núñez M.T. Iron and glutathione at the crossroad of redox metabolism in neurons. Biol. Res. 39 (2006) 157-165
5. Atasoy H.T., Nuyan O., Tunc T., Yorubulut M., Unal A.E., and Inan L.E. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol. India 52 (2004) 332-337
6. Beard J. Iron deficiency alters brain development and functioning. J. Nutr. 133 Suppl. 1 (2003) 1468-1472
7. Berg D., and Hochstrasser H. Iron metabolism in Parkinsonian syndromes. Mov. Disord. 9 (2006) 1299-1310
8. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., Dolan K.G., Haile D.J., Beard J.L., and Connor J.R. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66 (2001) 1198-1207
9. Canonne-Hergaux F., Gruenheid S., Ponka P., and Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood 93 (1999) 4406-4417
10. Cheah J.H., Kim S.F., Hester L.D., Clancy K.W., Patterson III S.E., Papadopoulos V., and Snyder S.H. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51 (2006) 431-440
11. Chinsangaram J., Moraes M.P., Koster M., and Grubman M.J. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol. 77 (2003) 1621-1625
12. Crawford G.D., Le W.D., Smith R.G., Xie W., Stefani E., and Appel S.H. A novel N18TG2 X mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12 (1992) 3392-3398
13. Ekshyyan O., and Aw T.Y. Apoptosis: a key in neurodegenerative disorders. Curr. Neurovasc. Res. 1 (2004) 355-371
14. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., and Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391 (1998) 43-50
15. Faucheux B.A., Hirsch E.C., Villares J., Selimi F., Mouatt-Prigent A., Javoy-Agid F., Hauw J.J., and Agid Y. Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease. J. Neurochem. 60 (1993) 2338-2341
16. Feng Z., and Zhang J.T. Protective effect of melatonin on β-amyloid-induced apoptosis in rat astroglioma c6 cells and its mechanism. Free Radic. Biol. Med. 37 (2004) 1790-1801
17. Fleming M.D., Trenor III C.C., Su M.A., Foernzler D., Beier D.R., Dietrich W.F., and Andrews N.C. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16 (1997) 383-386
18. Gerlach M., Double K.L., Youdim M.B., and Riederer P. Potential sources of increased iron in the substantia nigra of parkinsonian patients. J. Neural Transm. Suppl. 70 (2006) 133-142
19. Gordon N. Iron deficiency and the intellect. Brain Dev. 25 (2003) 3-8
20. Gotz M.E., Double K., Gerlach M., Youdim M.B., and Riederer P. The relevance of iron in the pathogenesis of Parkinson's disease. Ann. N. Y. Acad. Sci. 1012 (2004) 193-208
21. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., and Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature (Lond.) 388 (1997) 482-488
22. Han Y.T., Han Z.W., Yu G.Y., Wang Y.J., Cui R.Y., and Wang C.B. Inhibitory effect of polypeptide from Chlamys farreri on ultravioletA-induced oxidative damage on human skin fibroblasts in vitro. Pharmacol. Res. 49 (2004) 265-274
23. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 2509-2514
24. He Y., Lee T., and Leong S.K. Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats. Neuroscience 91 (1999) 579-585
25. Huang E., Ong W.Y., and Connor J.R. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience 128 (2004) 487-496
26. Jellinger K., Paulus W., Grundke-Iqbal I., Riederer P., and Youdim M.B. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J. Neural Transm. Park. Dis. Dement. Sec. 2 (1990) 327-340
27. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 (2003) 26-36
28. Jiang H., Qian Z.M., and Xie J.X. The increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice. Acta Physiol. Sin. 55 (2003) 571-576
29. Jiang H., Luan Z., Wang J., and Xie J.X. Neuroprotective effects of iron chelator desferal on dopaminergic neurons in the substantia nigra of rats with iron overload. Neurochem. Int. 49 (2006) 605-609
30. Jiang H., Song N., Wang J., Ren L.Y., and Xie J.X. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem. Int. 51 (2007) 32-36
31. Kidd P.M. Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. Altern. Med. Rev. 5 (2000) 502-529
32. Lee P.L., Gelbart T., West C., Halloran C., and Beutler E. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol. Dis. 24 (1998) 199-215
33. Levenson C.W., and Tassabehji N.M. Iron and ageing: an introduction to iron regulatory mechanisms. Age. Res. Rev. 3 (2004) 251-263
34. Mascola J.R., Sambor A., Beaudry K., Santra S., Welcher B., and Louder M.K. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. J. Virol. 79 (2005) 771-779
35. Moos T., and Morgan E.H. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann. N. Y. Acad. Sci. 1012 (2004) 14-26
36. Nagatsu T. Parkinson's disease: changes in apoptosis-related factors suggesting possible gene therapy. J. Neural Transm. 109 (2002) 731-745
37. Shindo M., Torimoto Y., Saito H., Motomura W., Ikuta K., Sato K., Fujimoto Y., and Kohgo Y. Functional role of DMT1 in transferrin-independent iron uptake by human hepatocyte and hepatocellular carcinoma cell, HLF. Hepatol. Res. 35 (2006) 152-162
38. Stohs S.J., and Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 18 (1995) 321-336
39. Suh Y.J., and Samuel D. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278 (2003) 27144-27148
40. Tatton G.W., Chalmers-Redman R., Brown D., and Tatton N. Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 53 Suppl. 3 (2003) 61-72
41. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
42. Wang J., Jiang H., and Xie J.X. Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system. Neurochem. Res. 29 (2004) 2239-2243
43. Wang J., Jiang H., and Xie J.X. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats. Eur. J. Neurosci. 25 (2007) 2766-2772
44. Wesley R.D., Tang M., and Lager K.M. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 22 (2004) 3427-3434
45. West M.J., Slomianka L., and Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivision of the rat hippocampus using the optical fractionator. Anatom. Rec. 231 (1991) 482-497
46. Worthington M.T., Browne L., Battle E.H., and Luo R.Q. Functional properties of transfected human DMT1 iron transporter. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) 1265-1273
47. Yao G., Yang L., Hu Y., Liang J., and Hou Y. Nonylphenol-induced thymocyte apoptosis involved caspase-3 activation and mitochondrial depolarization. Mol. Immunol. 43 (2006) 915-926
48. Youdim M.B., and Ben-Shachar D. The neurotoxic component in Parkinson's disease may involve iron-melanin interaction and lipid peroxidation of substantia nigra. In: Dostert P., Riederer P., Strolin-Benedetti M., and Roncucci R. (Eds). Early Markers in Parkinson's and Alzheimer's Diseases (1990), Springer-Verlag, Vienna 111-122
49. Youdim M.B., Stephenson G., and Ben Shachar D. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann. N. Y. Acad. Sci. 1012 (2004) 306-325
50. Zhang L., Lee T., Wang Y., and Soong T.W. Heterologous expression, functional characterization and localization of two isoforms of the monkey iron transporter Nramp2. Biochem. J. 349 (2000) 289-297 (Printed in Great Britain)
51. Zhang Z.H., Wei T.T., Hou J.W., Li G.S., Yu S.Z., and Xin W.J. Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. Eur. J. Pharmacol. 467 (2003) 41-47